top of page

Neosoma Platform
- Neosoma Brain Mets
- Neosoma Glioma
Reimbursement
Publications
About Us
News Feed
Contact
More

Use tab to navigate through the menu items.

Schedule A Demo

Paul Meskell, PhD

Clinical Commercialization

Paul Meskell, PhD

1-877-NEOSOMA (636-7662)

Company

View Our Research

Indications for Use

Get Started

Schedule A Demo

Reach Out to Collaborate

Resources

Terms of Service

© 2026 Neosoma, Inc.

Neosoma Glioma and Neosoma Brain Mets are FDA cleared.

U.S. Pat. 11,526,994 and 12,165,330

bottom of page